Physician profile
Edward Azar
NPI 1003291832
$18,035.14
in general payments reported to CMS, 2019-2025
38 companies · $9,314 in 2025
The $9,314 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $861 · 2020: $208 · 2021: $869 · 2022: $1,139 · 2023: $4,094 · 2024: $1,551 · 2025: $9,314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,498 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,460 · Travel and Lodging: $3,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,497.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,460.00 |
| Travel and Lodging | $3,000.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $8,277.47 | 2021-2025 | Nuzyra |
| Mylan Specialty L.P. | $1,987.88 | 2023 | |
| Smith+Nephew, INC. | $1,407.98 | 2019-2025 | Grafix, Stravix, Collagenase Santyl |
| Abbvie INC. | $1,279.31 | 2021-2025 | Dalvance |
| Kerecis Limited | $869.97 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Angiodynamics, INC. | $573.46 | 2021-2022 | |
| Stryker Corporation | $536.52 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Dart-Fire |
| Cardiovascular Systems INC. | $506.17 | 2020-2023 | Diamondback Peripheral |
| Biotissue Holdings INC. | $318.48 | 2019 | |
| Averitas Pharma INC. | $298.40 | 2023-2025 | Qutenza |
| Linvatec Corporation | $226.05 | 2025 | Biobrace 23mm, 5ms, Allograft Tissue |
| Wright Medical Technology, INC. | $186.17 | 2019 | |
| Amgen INC. | $178.36 | 2024-2025 | Krystexxa |
| Horizon Therapeutics Plc | $147.09 | 2023 | Krystexxa |
| Amniox Medical, INC. | $145.64 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $136.28 | 2019-2020 | |
| Inari Medical, INC. | $125.39 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Paragon 28, INC. | $124.77 | 2023 | Portfolio |
| Tactile Systems Technology INC | $102.90 | 2021-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Mimedx Group, INC. | $95.29 | 2025 | |
| Grt US Holding, INC. | $56.08 | 2022 | |
| Depuy Synthes Sales INC. | $54.28 | 2024-2025 | |
| Advanced Oxygen Therapy INC. | $53.83 | 2025 | Topical Oxygen Chamber For Extremities |
| Allergan, INC. | $53.26 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $43.93 | 2019 | |
| Bioventus LLC | $35.62 | 2023 | Exogen Ultrasound Bone Healing System |
| Djo, LLC | $29.90 | 2020 | |
| Nabriva Therapeutics, Plc | $28.07 | 2021-2022 | |
| Nevro Corp. | $23.34 | 2024 | Senza |
| Integra Lifesciences Corporation | $22.82 | 2019 | |
| Organogenesis INC. | $20.39 | 2025 | Apligraf |
| Solventum Corporation | $19.86 | 2025 | Activ.A.C. |
| Osiris Therapeutics INC. | $18.04 | 2019 | |
| Abbott Laboratories | $17.41 | 2024 | Proclaim |
| Venclose INC. | $15.31 | 2020 | |
| Kci USA, INC. | $11.86 | 2022 | |
| Electronic Waveform Lab, INC. | $7.56 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,932.71 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Azar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.